Codex Genetics, a leading precision diagnostics company headquartered in Hong Kong, today announces a strategic collaboration with C2N Diagnostics (C2N), a global leader in in advanced brain health ...

Please provide your email address to receive an email when new articles are posted on . A genetic biomarker test was able to predict patients’ semaglutide treatment response after bariatric surgery.

Over 20% of high-grade serous ovarian cancer patients have BRCA mutations, and up to 50% exhibit HRD, impacting DNA repair pathways. Global guidelines recommend BRCA and HRD testing, but many eligible ...

Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a one-size-fits-all approach. Biomarkers serve diagnostic, prognostic, and predictive roles ...

It’s common to wait until something feels “off” before making an appointment to see a healthcare provider. But waiting for noticeable symptoms can mean missing the chance to catch health issues early.

A new Nature Aging study shows that simple blood tests can detect Alzheimer's and frontotemporal dementia with up to 96% accuracy in Latin American populations — genetically diverse groups that have ...

Researchers have evaluated a simple blood test measuring plasma p-tau217 in nearly 600 Latin Americans across six countries, adding large-scale evidence that a potentially lower-cost screening tool ...

Cancer diagnosis used to be a simple, binary call: either someone had the disease or they didn’t. And patients with the same broad class of cancer tend to receive the same class of therapy. It was a ...

The KIM-1 blood marker in kidney cancer offers a reliable method to monitor treatment efficacy, potentially reducing reliance on imaging scans. RETAIN-2 trial in bladder cancer suggests that patients ...

Imagine this: someone you love has just heard the words “you have cancer.” They are meeting with their oncologist – perhaps even me, or one of my colleagues – and come to understand that there is ...

Biomarkers, or biological markers, are essentially your body’s health signals. They’re measurable indicators of what’s happening beneath the surface of your body, and they can often provide insight ...

In 2022, Arizona was one of the first states in the nation to pass legislation (House Bill 2144) requiring Medicaid and commercial insurance plans to cover qualified biomarker tes ...